Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Kang-Yao Zeng, Qing-Yi Zhou, Yun-Xi Zhang, Zhe-Sheng Chen, Zhi Shi, Song-Wang Cai, Apoptozole Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer , Journal of Cancer Research Updates: Vol. 14 (2025)
- Sh.R. Kzyrgalin, K.Sh. Gantsev, A.A. Rizvanov, Sh.Kh. Gantsev, New Insight of Oncology: Cancer Concept without Tumor , Journal of Cancer Research Updates: Vol. 13 (2024)
- Gregory Loewen, Ying Zhuo, Yan Zhuang, Janarthanan Jayawickramarajahand, Bin Shan, lincRNA HOTAIR as a Novel Promoter of Cancer Progression , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Ali Muafaq Said, Ayat Ali Salih, Mohammed Abdulridha Obid, Azal Hamoody Jumaa, Youssef Shakuri Yasin, A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA/CoA Ratio via Dual Inhibition of PPAT and CPT1A , Journal of Cancer Research Updates: Vol. 14 (2025)
- Sura Findakly, Aiad Gaber Arean, Saba Jesem Alheshemi, Henan Dh. Skheel Aljebori, Dual-Targeting of β-Tubulin and Carbonic Anhydrase IX by Albendazole-Etoricoxib Combination Induces Synergistic Cytotoxicity and Energetic Strangulation in Cervical Cancer Cells , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Nur Syahada Ab Razak, Nadiah Abu, Chemotherapy-Associated Extracellular Vesicles Modulate T Cells Activity and Cytokine Release , Journal of Cancer Research Updates: Vol. 13 (2024)
- Deepti Sharma, Abi M. Thomas, George Koshy, Tumor Infiltrating Lymphocytes as Immunebiomarkers in Oral Cancer: An Update , Journal of Cancer Research Updates: Vol. 12 (2023)
- Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards, Rebecca C. Fry, Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Lydia Hopp, Edith Willscher, Henry Löffler-Wirth, Hans Binder, Function Shapes Content: DNA-Methylation Marker Genes and their Impact for Molecular Mechanisms of Glioma , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
You may also start an advanced similarity search for this article.